dc.contributor | Hospital Universitari de Girona Dr Josep Trueta |
dc.contributor.author | Aliaga-Gaspar, Pablo |
dc.contributor.author | Hurtado Guerrero, Isaac |
dc.contributor.author | Ciano-Petersen, Nicolás Lundahl |
dc.contributor.author | Urbaneja, Patricia |
dc.contributor.author | Brichette-Mieg, I. |
dc.contributor.author | Reyes, Virginia |
dc.contributor.author | Quintana, Ester |
dc.contributor.author | Ramió-Torrentà, Lluís |
dc.date.accessioned | 2022-01-31T13:23:32Z |
dc.date.available | 2022-01-31T13:23:32Z |
dc.date.issued | 2021-12-16 |
dc.identifier.citation | Aliaga-Gaspar P, Hurtado-Guerrero I, Ciano-Petersen NL, Urbaneja P, Brichette-Mieg I, Reyes V, et al. Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment. Front Immunol. 2021 Dec 16;12:778204 |
dc.identifier.issn | 1664-3224 |
dc.identifier.uri | https://hdl.handle.net/11351/6940 |
dc.description | Empalmament alternatiu; Receptors solubles; IFNAR; Interferó beta; Esclerosi múltiple |
dc.description.sponsorship | This research was funded by grants from the Instituto de Salud Carlos III and co-funded by European Regional Development Fund (ERDF), Technological Development Project in health DTS/1800045 to BO-M. BO-M holds a contract from Red Andaluza de Investigacion Clínica y Traslacional en Neurología (Neuro-reca) (RIC-0111-2019). PA-G is supported by Promoción de Empleo Joven e Implantación de la Garantía Juvenil 2018 (PEJ2018-002719-A). JR-B is supported by grants from Red Temática de Investigación Cooperativa, Red Española de Esclerosis Multiple REEM (RD16/0015/0010). LL holds a Nicolás Monardes research contract (RC-002-2019) from the Andalusian Ministry of Health and Family. IB-M holds a pFIS contract (FI19/00139) from the Spanish Science and Innovation Ministry. |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Immunology;12 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Interferó |
dc.subject | Esclerosi múltiple - Tractament |
dc.subject.mesh | Multiple Sclerosis |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Interferon-beta |
dc.title | Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fimmu.2021.778204 |
dc.subject.decs | esclerosis múltiple |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | interferón beta |
dc.relation.publishversion | https://doi.org/10.3389/fimmu.2021.778204 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Aliaga-Gaspar P] Neuroimmunology and Neuroinflammation Group, Instituto de Investigación Biomédica de Málaga (IBIMA), Unidad de Gestión Clínica (UGC) Neurociencias, Hospital Regional Universitario de Málaga, Málaga, Spain. Facultad de Medicina, Universidad de Málaga, Málaga, Spain. [Hurtado-Guerrero I] Neuroimmunology and Neuroinflammation Group, Instituto de Investigación Biomédica de Málaga (IBIMA), Unidad de Gestión Clínica (UGC) Neurociencias, Hospital Regional Universitario de Málaga, Málaga, Spain. Neuroinflammation Unit, Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, Copenhagen Biocentre, University of Copenhagen, Copenhagen, Denmark. [Ciano-Petersen NL, Urbaneja P, Reyes V] Neuroimmunology and Neuroinflammation Group, Instituto de Investigación Biomédica de Málaga (IBIMA), Unidad de Gestión Clínica (UGC) Neurociencias, Hospital Regional Universitario de Málaga, Málaga, Spain. Red Andaluza de Investigación Clínica y Traslacional en Neurología (Neuro-Reca), Málaga, Spain. [Brichette-Mieg I] Neuroimmunology and Neuroinflammation Group, Instituto de Investigación Biomédica de Málaga (IBIMA), Unidad de Gestión Clínica (UGC) Neurociencias, Hospital Regional Universitario de Málaga, Málaga, Spain. [Quintana E] Red Española de Esclerosis Múltiple (REEM), Madrid, Spain. Servicio de Neurología, Hospital Universitari de Girona Doctor Josep Trueta, Intitut Català de la Salut (ICS), Girona, Spain. [Ramió-Torrentà L] Red Española de Esclerosis Múltiple (REEM), Madrid, Spain. Servicio de Neurología, Hospital Universitari de Girona Doctor Josep Trueta, Intitut Català de la Salut (ICS), Girona, Spain. Institut d’Investigació Biomèdica de Girona (IDIBGI), Salt, Spain. Departament de Ciències Mèdiques, Facultat de Medicina, Universitat de Girona, Girona, Spain |
dc.identifier.pmid | 34975865 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |